Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Theravance Biopharma, Inc. (TBPH) had Free Cash Flow per Share of $0.87 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$15.39M |
|
$-13.58M |
|
-- |
|
$15.39M |
|
$29.82M |
|
$-14.43M |
|
$0.30M |
|
$-14.14M |
|
$-14.14M |
|
$-13.58M |
|
$-13.58M |
|
$-13.58M |
|
$-13.58M |
|
$-14.43M |
|
$-14.35M |
|
49.71M |
|
49.71M |
|
$-0.27 |
|
$-0.27 |
|
| Balance Sheet Financials | |
$150.26M |
|
$7.03M |
|
$193.32M |
|
$343.58M |
|
$31.50M |
|
-- |
|
$146.10M |
|
$177.60M |
|
$165.98M |
|
$165.98M |
|
$165.98M |
|
50.00M |
|
| Cash Flow Statement Financials | |
$43.04M |
|
$30.63M |
|
$-0.85M |
|
$38.63M |
|
$111.45M |
|
$72.82M |
|
$4.88M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.77 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-93.80% |
|
-93.80% |
|
-- |
|
-91.88% |
|
-88.24% |
|
$43.04M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
1.00 |
|
89.80 |
|
-8.18% |
|
-8.18% |
|
-3.95% |
|
-8.18% |
|
$3.32 |
|
|
Free Cash Flow per Share |
$0.87 |
$0.87 |
|